Table 2.
PCR primers used in this study.
| Primers | Sequence |
|---|---|
| Human GAPDH (Forward) | 5’-TTCGACAGTCAGCCGCAT-3’ |
| Human GAPDH (Reverse) | 5’-CGACCAAATCCGTTGACTCC-3’ |
| Human ACTB (Forward) | 5’-CACCATTGGCAATGAGCGGTTC-3’ |
| Human ACTB (Reverse) | 5’-AGGTCTTTGCGGATGTCCACGT-3’ |
| Human DNAI2 (Forward) | 5’-ACCCGAAGAACTTCCTGACG-3’ |
| Human DNAI2 (Reverse) | 5’-ACACCCATTGTCCTTCAAGCTG-3’ |
| Human FOXJ1 (Forward) | 5’-ACTCGTATGCCACGCTCATCTG-3’ |
| Human FOXJ1 (Forward) | 5’-GAGACAGGTTGTGGCGGATTGA-3’ |
| Human FOXA3 (Forward) | 5’-CTCGCTGTCTTTCAACGACTGC-3’ |
| Human FOXA3 (Reverse) | 5’-CGCAGGTAGCAGCCATTCTCAA-3’ |
| Human MUC5AC (Forward) | 5’-CAGACTTGGGCACTGGTGCTG-3’ |
| Human MUC5AC (Forward) | 5’-TTCTCCGGCCTCATCTTCTCC-3’ |
| Human HES1 (Forward) | 5’-GGAAATGACAGTGAAGCACCTCC-3’ |
| Human HES1 (Reverse) | 5’-GAAGCGGGTCACCTCGTTCATG-3’ |
| Human HES2 (Forward) | 5’-AACCAGAGCCTGAGCCAGCTTA-3’ |
| Human HES2 (Reverse) | 5’-TGCAGGAAGCGCACGGTCATTT-3’ |
| Human CDHR3 (Forward) | 5’- TAAAGACCTCCCCCAGAGCA-3’ |
| Human CDHR3 (Reverse) | 5’- TGTTGGTGGCCTGGATTCTG-3’ |